Trigeminal n eu ra l gia diagnosis - a c ha l lenge - a cros s-se ct ional sur ve y to a ssess the k nowledge and a ttit ud e among t he dentists of S au di A ra bia.

Autor: Dossery FA; Dar Al Uloom University, Riyadh, Saudi Arabia., Mutlaq AA; Dar Al Uloom University, Riyadh, Saudi Arabia., Almegbil N; Dar Al Uloom University, Riyadh, Saudi Arabia., Alamoudi Y; Dar Al Uloom University, Riyadh, Saudi Arabia., Tabassum N; Department of Dental Surgical and Diagnostic Sciences, Dar Al Uloom University, Riyadh, Saudi Arabia., Alqahtani NR; Department of Oral and Maxillofacial S urgery and diagnostic Sciences, College of Dentistry, Prince S attam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.

Publikováno v: JPMA. The Journal of the Pakistan Medical Association [J Pak Med Assoc] 2024 Aug; Vol. 74 (8), pp. 1475-1480.

Design of perovskite solar brick for textile ceramic technology

Autor: Casariego, P., Sarrablo, V., De Rossi, F., Ibraikulov, O.A., Cros, S., Brunetti, F.

Publikováno v: In Construction and Building Materials 8 November 2024 450

SOFT TISSUE SARCOMAS – A CROS S SECTIONAL STUDY AT MNJIO

Autor: Ramesh Maturi, Srinivasulu Mukta, Manikumari Manikumari, Mujtaba Mujtaba

Publikováno v: Journal of Evidence Based Medicine and Healthcare, Vol 2, Iss 27, Pp 3989-3994 (2015)

BACKGROUND: Sarcomas are an uncommon group of cancers with a wide distribution in the various anatomical regions of the body and even wider and confusing range of histopathological diagnosis. AIMS: To study the mode of presentation, histology, treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecbb2f4f3061bd4393a70e20d5121c61

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.

Autor: Jiménez N; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain., Garcia de Herreros M; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain., Reig Ò; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Marín-Aguilera M; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain., Aversa C; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain., Ferrer-Mileo L; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain., García-Esteve S; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Rodríguez-Carunchio L; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital Clínic, Barcelona, Spain., Trias I; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital Clínic, Barcelona, Spain., Font A; Medical Oncology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain., Rodriguez-Vida A; Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain., Climent MÁ; Medical Oncology Service, Instituto Valenciano de Oncología (IVO), Valencia, Spain., Cros S; Medical Oncology Department, Hospital General de Granollers, Barcelona, Spain., Chirivella I; Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., Domènech M; Medical Oncology Department, Fundació Althaia, Xarxa Assistencial Universitària de Manresa, Spain., Figols M; Medical Oncology Department, Fundació Althaia, Xarxa Assistencial Universitària de Manresa, Spain., Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Suárez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Herrero Rivera D; Medical Oncology Department, Hospital Virgen del Rocío, Sevilla, Spain., González-Billalabeitia E; Medical Oncology Department, University Hospital, 12 de Octubre, Madrid, Spain., Cívico C; Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia, Spain., Sala-González N; Department of Medical Oncology, Institut Català d'Oncologia, Girona, Spain., Ruiz de Porras V; Badalona Applied Research Group in Oncology (B-ARGO), Institut Català d'Oncologia - Germans Trias i Pujol Research Institute, Badalona, Spain., Ribal MJ; Department of Urology, Hospital Clínic, Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Mellado B; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: bmellado@clinic.cat.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 954-964. Date of Electronic Publication: 2024 Mar 01.

Efectos de la estimulación interfibrilar contrairritante musculoesquelética en epicondilalgias de jugadores de pádel amateurs. Estudio piloto

Autor: Campos, C., Cros, S., del Estal, C., Doménech, M., Salvat, I.

Publikováno v: In Fisioterapia July-August 2017 39(4):158-165